A randomized trial of Parkinson’s disease across three population-based cohorts
Minh Nguyễn1*
(unauthenticated), Thandiwe Okafor2, Stefan Johansson3
1School of Economics, Hanseatic University of Applied Sciences, Germany
2Department of Biomedical Sciences, Sapienza Mediterranea, Italy
3Department of Linguistics, University of Eastfield, United Kingdom
* Corresponding author.
Cascadia J. Biomed. Res. 2026, 18(1); https://doi.org/10.58302/sa7wvg60
Abstract
Hypertension have attracted growing attention because of their relevance to both theory and practice. In contrast to earlier studies, our approach accounts for heterogeneity and avoids the usual simplifying assumptions. We find a distinct transcriptional program in the responding group. We discuss limitations of the present study and outline how the methods can be extended.
Declarations
Competing Interests
The authors declare no competing interests.
Data Availability
Source code and data are available at a public repository; the link is provided in the Methods section.
Ethics Statement
No ethics approval was required for this study.
Copyright and License
© 2026 Cascadia Health Sciences Publishing